Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 44th Annual J.P. Morgan Healthcare ...
2030 ambition to help more than 500 million people worldwide achieve their full health potential Showcases integration of intelligent products and solutions within the ResMed ecosystem, designed to ...
Personal Therapy Assistant feature for AirSense 11 users, seen here within the myAir app SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) -- ResMed, a global leader in digital health and sleep apnea ...
ResMed announced it will release its financial and operational results for the second quarter of fiscal year 2025 on January 30, 2025, after the stock market closes. Following the release, management ...
Visit a quote page and your recently viewed tickers will be displayed here.
Acquisition supports Resmed’s growth in virtual care, expands access to diagnosis, and enhances the digital experience for patients and providers SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) — Resmed ...
SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has ...
Good afternoon, everybody. My name is Lyanne Harrison. I am the Australian health care analyst here for Bank of America, and I cover ResMed. Today, I have the pleasure of introducing Mick Farrell, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback